Apoptotic and necrotic cell death are well characterized and are influenced by intracellular ATP levels. Poly(ADP-ribose) polymerase (PARP), a nuclear enzyme activated by DNA strand breaks, physiologically participates in DNA repair. Overactivation of PARP after cellular insults can lead to cell death caused by depletion of the enzyme's substrate ␤-nicotinamide adenine dinucleotide and of ATP. In this study, we have differentially elicited apoptosis or necrosis in mouse fibroblasts. Fibroblasts from PARP-deficient (PARP ؊͞؊ ) mice are protected from necrotic cell death and ATP depletion but not from apoptotic death. These findings, together with cell death patterns in PARP ؊͞؊ animals receiving other types of insults, indicate that PARP activation is an active trigger of necrosis, whereas other mechanisms mediate apoptosis. P oly(ADP-ribose) polymerase (PARP; EC 2.4.2.30) is a nuclear enzyme activated by DNA strand breaks, which transfers 50-200 branched chains of ADP-ribose to a variety of nuclear proteins including PARP itself (1, 2). With moderate amounts of DNA damage, PARP is thought to participate in the DNA repair process (3). However, with excessive activation of PARP, its substrate ␤-nicotinamide adenine dinucleotide (NAD ϩ ) is depleted, and, in efforts to resynthesize NAD ϩ , ATP is also depleted such that cells may die from energy loss (4-6). A role for PARP overactivation in cell death is indicated by the protection against cell death observed after treatment with PARP inhibitors (7, 8) and the pronounced protection against neuronal ischemia (9, 10), myocardial ischemia (11), and diabetic pancreatic damage (12) (13) (14) Cells can die by energy-dependent apoptosis or by necrosis (18, 19) . Because overactivation of PARP depletes ATP, we wondered whether this mode of cell death might be selectively associated with necrosis rather than apoptosis. Accordingly, we have compared cellular models of necrosis and apoptosis. To minimize contaminating variables, we employed a single cell type in which different stimuli can elicit necrosis or apoptosis differentially. We used fibroblasts in which DNA-damaging agents such as N-methyl-NЈ-nitro-N-nitrosoguanidine (MNNG) and hydrogen peroxide (H 2 O 2 ) elicit necrosis at high concentration, whereas activation of Fas leads to apoptosis (16, 20, 21) . We show that PARP Ϫ͞Ϫ fibroblasts are protected from necrotic but not apoptotic death and that necrosis but not apoptosis is associated with ATP depletion.
Ϫ͞Ϫ
mice are not protected against cell death elicited by tumor necrosis factor-␣ and ␣-CD95 (␣-Fas) in hepatocytes (16) , and ␥-irradiation induced killing of PARP Ϫ͞Ϫ mice (17) . Cells can die by energy-dependent apoptosis or by necrosis (18, 19) . Because overactivation of PARP depletes ATP, we wondered whether this mode of cell death might be selectively associated with necrosis rather than apoptosis. Accordingly, we have compared cellular models of necrosis and apoptosis. To minimize contaminating variables, we employed a single cell type in which different stimuli can elicit necrosis or apoptosis differentially. We used fibroblasts in which DNA-damaging agents such as N-methyl-NЈ-nitro-N-nitrosoguanidine (MNNG) and hydrogen peroxide (H 2 O 2 ) elicit necrosis at high concentration, whereas activation of Fas leads to apoptosis (16, 20, 21) . We show that PARP Ϫ͞Ϫ fibroblasts are protected from necrotic but not apoptotic death and that necrosis but not apoptosis is associated with ATP depletion.
Materials and Methods
Cell Culture. Mouse embryonic fibroblasts (MEFs) derived from both wild-type and PARP knockout mice were kindly provided by Z. Q. Wang (Institute of Molecular Pathology, Vienna). MEFs were cultured at 37°C (5% CO 2 ) in DMEM supplemented with 10% (vol͞vol) FBS, 2 mM L-glutamine, 100 units͞ml penicillin, and 100 g͞ml streptomycin. MEFs were seeded in 6-well plates at Ϸ70% conf luence (exponential phase of growth). Cell numbers were similar for PARP Ϫ͞Ϫ and PARP ϩ͞ϩ MEFs within a given experiment. MNNG was prepared freshly in DMSO such that the final concentration of the solvent was 0.5% (vol͞vol) when added to the culture medium. Hydrogen peroxide was diluted in PBS (pH 7.4) and added to the cells at various concentrations.
Western Blotting. MEFs were collected by centrifugation after removal from culture plates with trypsin and dissolved in sample buffer (50 l per 10 6 cells) containing 62.5 mM Tris⅐HCl (pH 6.8), 6 M urea, 10% (vol͞vol) glycerol, 2% (vol͞vol) SDS, 5% (vol͞vol) ␤-mercaptoethanol, 1 mM DTT, 0.00125% bromophenol blue with freshly prepared protease inhibitors, 1 mM phenylmethylsulfonyl fluoride, 0.001% aprotinin, and 0.001% leupeptin. After sonication for 30 s and incubation at 65°C for 10 min, the proteins (20 l) were separated by SDS͞PAGE on a 4-12% gel and transferred to nitrocellulose membranes (Schleicher & Schuell) for Western blot analyses. The blots were blocked in 5% (vol͞vol) nonfat dry milk in PBS-Tween [0.1% (vol͞vol) Tween 20] and incubated with PARP antibody at 1:5,000 dilution (SA252, Biomol, Plymouth Meeting, PA), which was based on sequence from the C-terminal portion of the bovine PARP automodification domain (residues 471-493), linked by a multiple antigenic peptide. ␤-actin (Sigma) was used as a loading control. The Amersham Pharmacia ECL system was used for detection. HL60 cell extracts (SW-101 and SW-102, Biomol) were used as a Western-blotting control to detect intact and cleaved PARP.
Measurement of ATP. Intracellular ATP was extracted from cells in the exponential phase of growth and measured by the luciferin͞luciferase method by using an ATP Determination Kit (Molecular Probes). The whole cell population, including any floating cells, was subjected to the assay. The reconstituted buffer (200 l) containing 0.5 mM luciferin, 1.25 g͞ml luciferase, 25 mM Tricine buffer (pH 7.8), 5 mM MgSO 4 , 100 M EDTA, and 1 mM DTT was mixed with cell lysate (20 l). Luminescence was analyzed after a 2-s delay with a 10-s integration on a Monolight 2010 luminometer (Analytical Luminescence Laboratory, San Diego). A standard curve was generated from known concentrations of ATP in each experiment and used to calculate the concentration of ATP in each sample. Luminescence increased linearly with the ATP concentration in the samples over the range of concentrations measured. The results were normalized by using either cell number or cellular protein as determined by a bicinchoninic acid protein assay (Pierce, Rockford, IL). The publication costs of this article were defrayed in part by page charge payment. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. §1734 solely to indicate this fact.
Cell Viability and Mitochondrial Membrane Potential Assays. Cell viability was determined by the mitochondrial-dependent reduction of 3-(4, 5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide (MTT) to MTT formazan as described. MTT was added to MEFs to a final concentration of 0.5 mg͞ml and incubated for 2 hr. The resulting MTT formazan crystals were dissolved by adding anhydrous isopropanol containing 0.1 N HCl. MTT reduction was determined spectrophotometrically at 570 nm. For measurement of mitochondrial membrane potential, adherent and nonadherent MEFs that were either treated with MNNG or untreated were harvested and incubated in 100 nM rhodamine 123 (Molecular Probes) for 15 min at 37°C as reported (22) . Cells were then washed twice, resuspended in PBS, and analyzed on a Becton Dickinson f luorescenceactivated cell sorter (FACScan).
Image Analysis. The mode of necrotic cell death was determined in part with the combination of two fluorescent dyes, propidium iodide and Hoechst 33342 (Molecular Probes), as described (23) . Both dyes stain DNA; however, propidium iodide is membrane impermeant and yields red fluorescent chromatin, whereas Hoechst 33342 is membrane permeant and yields blue pseudo 
Results

PARP Activity
Regulates Intracellular ATP Levels. In Western blot analysis, PARP protein is absent from the fibroblasts of PARP Ϫ͞Ϫ animals (Fig. 1A) . Treating the fibroblasts with MNNG, a potent DNA alkylating agent, leads to pronounced activation of PARP catalytic activity reflected in transfer of [ 32 P]NAD ϩ to PARP protein as ADP-ribose groups (Fig. 1B) . Treatment with MNNG for 1 hr depletes ATP from fibroblasts in a concentration-dependent fashion (Fig. 1C) . Virtually complete protection against MNNG-induced ATP depletion is evident in PARP Ϫ͞Ϫ fibroblasts with substantial protection afforded to wild-type fibroblasts by the PARP inhibitor DPQ.
We also examined H 2 O 2 , which is well known to induce oxidative stress leading to DNA damage (Fig. 1D ). H 2 O 2 also depletes ATP from wild-type fibroblasts in a time-and concentration-dependent fashion. PARP Ϫ͞Ϫ cells are completely pro- Mitochondrial membrane potential assessed with rhodamine 123 is also greatly diminished in wild-type fibroblasts and protected in PARP Ϫ͞Ϫ preparations treated with 5 mM MNNG for various time points (Fig. 1E) . Hence, overactivation of PARP leads to the loss of mitochondrial membrane potential. of cell viability, we monitored the conversion of MTT to MTT formazan (Fig. 2B) . MNNG markedly reduces this conversion in wild-type cells, consistent with loss of viability, whereas PARP Ϫ͞Ϫ fibroblasts are protected. MNNG seems to kill fibroblasts by necrosis.
Plasma membrane integrity is maintained in apoptosis but lost in necrosis (24) (25) (26) (27) . We stained fibroblasts with two DNAbinding dyes, propidium iodide, which is colored red and does not penetrate intact cell membranes, and Hoechst 33342, which is colored blue and readily penetrates cell membranes (Fig. 2C) . In wild-type cells treated with MNNG, nuclei stain intensely for propidium iodide, consistent with a necrotic process. By contrast, nuclei from PARP Ϫ͞Ϫ fibroblasts do not stain for propidium iodide but only for Hoechst 33342, consistent with their protection from necrosis. At the 3 and 6 hr times used for the propidium iodide experiments and with the 2.5-10 mM concentration of MNNG employed, ATP levels are fully depleted in wild-type fibroblasts but completely protected in PARP Ϫ͞Ϫ cells (data not shown).
MNNG induces necrotic cell death without PARP cleavage (Fig. 2D) , which is typically associated with apoptotic cell death (28) . Also, MNNG induces DNA smear, which is typically associated with necrosis, in wild-type fibroblasts and, to a lesser extent, in PARP Ϫ͞Ϫ fibroblasts (Fig. 2E) , indicating that DNA damage is still occurring in the absence of cell death in PARP Ϫ͞Ϫ fibroblasts. The absence of PARP cleavage and internucleosomal DNA fragmentation indicates that caspases are not activated in MNNG-induced necrotic cell death.
Fas Induces Apoptosis Without ATP Depletion. To evaluate apoptosis, we used Fas, also known as ␣-CD95. Fas is a membrane protein that triggers apoptotic cell death when activated by anti-Fas antibodies in conjunction with CHX. In wild-type fibroblasts, Fas activation elicits DNA laddering, which is typically associated with apoptosis (Fig. 3A) . Internucleosomal DNA fragmentation in PARP Ϫ͞Ϫ fibroblasts is essentially the same as in wild type. Apoptosis is also characterized by membrane-bound nuclear fragments (24) (25) (26) (27) . Fas activation elicits nuclear fragmentation to a similar extent in wild-type and PARP Ϫ͞Ϫ fibroblasts (Fig. 3B) .
Fas activation also decreases MTT conversion, indicating both a loss of cell viability and mitochondrial respiration, to a similar extent in wild-type and PARP Ϫ͞Ϫ fibroblasts (Fig. 3C) . Unlike the necrotic process associated with MNNG or H 2 O 2 treatment, Fas activation does not deplete ATP with no differences between wild-type and PARP Ϫ͞Ϫ fibroblasts (Fig. 3D) . In apoptotic cell death, PARP is typically cleaved (28) . We observe PARP cleavage in Fas-activated fibroblasts but not in MNNG-treated cells, consistent with Fas activation reflecting apoptosis and MNNG treatment involving necrosis (Fig. 3E) .
Discussion
Apoptosis is an active process requiring energy, whereas necrosis has been considered as a passive process. In the present study, we have shown that DNA-damage-induced PARP overactivation depletes intracellular ATP levels irreversibly and induces necrotic cell death, whereas, in PARP Ϫ͞Ϫ cells, intracellular ATP levels are maintained without necrotic cell death. On the other hand, after Fas stimulation, both PARP ϩ͞ϩ and PARP Ϫ͞Ϫ fibroblasts maintain intracellular ATP levels and are equally susceptible to apoptosis. Thus, PARP activation seems to regulate the mode of cell death by influencing intracellular ATP levels. This conclusion is consistent with other evidence that depletion of ATP can transform an ongoing apoptotic process into necrosis, suggesting that intracellular ATP levels regulate the mode of cell death (29, 30) .
Our findings that PARP deletion protects against necrotic but not apoptotic cell death can explain discrepant results previously reported on the role of PARP in cell death (Table 1) . Thus, PARP deletion protects against neurotoxicity caused by activation of glutamate N-methyl-D-aspartate receptors (9, 10), myocardial ischemia (11) , inflammation elicited by zymosan, bacterial lipopolysaccharide plus interferon-␥, and trinitrobenzenesulfonic acid (31) (32) (33) , as well as streptozotocin-induced diabetes (12) (13) (14) . In all of these models, abundant evidence indicates that cell death occurs by a necrotic process (24) (25) (26) (27) . PARP deletion fails to protect against tumor necrosis factor-␣ and CD95-induced death of hepatocytes (16) as well as death of thymocytes elicited by agents such as ceramide, dexamethasone, etoposide, or ionomycin (16) . These forms of cell death are well charac- terized as apoptotic (16) . Furthermore, it has been reported recently that PARP inhibitors block necrotic cell death, but not apoptosis, in Burkitt's lymphoma (34) , endothelial (35) , and epithelial cells (36) . In these studies, PARP inhibitors reverse the mode of cell death from necrosis to apoptosis. These findings, together with results reported here, show a consistent link between PARP and necrosis and the absence of a relationship between PARP and apoptosis.
In apoptosis, PARP protein is typically cleaved and inactivated, which may preserve cellular ATP by preventing its depletion through excessive PARP activation. Preservation of ATP by PARP cleavage thus affords the energy required for apoptosis. This model is supported by a recent report showing that expression of caspase-resistant PARP in fibroblasts transforms apoptosis to necrosis associated with depletion of NAD ϩ and ATP (37). PARP's abundance and very high catalytic activity presumably enable its excess activation to mediate this switching of the mode of cell death.
We directly show that PARP activation is required for necrotic cell death, suggesting that this enzyme activation may be regarded as an ''active'' key link in necrotic cell death. Moreover, because inhibition of PARP activity or PARP gene deletion can inhibit both depletion of ATP and induction of necrosis, PARP overactivation induced-necrosis is an active process rather than a passive one. In many clinical instances, such as inflammation, vascular stroke, and myocardial infarction, necrosis seems to be the predominant mode of cell death. Accordingly, drugs that inhibit PARP might be expected to be therapeutic. In animal models, PARP inhibition by drugs or gene deletion diminishes tissue damage associated with stroke and myocardial infarct (9) (10) (11) .
